MedPath

MAYO CLINIC

MAYO CLINIC logo
🇺🇸United States
Ownership
Subsidiary
Established
1889-01-01
Employees
10K
Market Cap
-
Website
http://www.mayoclinic.org

Durvalumab and Lurbinectedin for the Treatment of Relapsed or Refractory Small Cell Lung Cancer

Phase 2
Recruiting
Conditions
Platinum-Sensitive Lung Small Cell Carcinoma
Refractory Extensive Stage Lung Small Cell Carcinoma
Platinum-Resistant Lung Small Cell Carcinoma
Recurrent Extensive Stage Lung Small Cell Carcinoma
Interventions
First Posted Date
2020-10-29
Last Posted Date
2024-12-30
Lead Sponsor
Mayo Clinic
Target Recruit Count
46
Registration Number
NCT04607954
Locations
🇺🇸

Mayo Clinic in Rochester, Rochester, Minnesota, United States

Nab-Paclitaxel + Cisplatin + Gemcitabine + TTF in pt. w/ Metastatic PAC

Phase 1
Recruiting
Conditions
Pancreas Cancer
Metastatic Adenocarcinoma
Pancreatic Adenocarcinoma
Metastatic Pancreatic Cancer
Interventions
Combination Product: Modified GCN+TTF treatment
First Posted Date
2020-10-28
Last Posted Date
2024-08-02
Lead Sponsor
Mayo Clinic
Target Recruit Count
40
Registration Number
NCT04605913
Locations
🇺🇸

Mayo Clinic, Jacksonville, Florida, United States

Impact of Predictive Modeling on Time to Palliative Care in an Outpatient Primary Care Population

Not Applicable
Completed
Conditions
Palliative Care
Interventions
Other: Palliative care contacts primary care
First Posted Date
2020-10-27
Last Posted Date
2021-06-16
Lead Sponsor
Mayo Clinic
Target Recruit Count
127070
Registration Number
NCT04604457
Locations
🇺🇸

Mayo Clinic in Rochester, Rochester, Minnesota, United States

Remote Self-training Program for Patients With Postural Orthostatic Tachycardia Syndrome

Not Applicable
Completed
Conditions
Postural Orthostatic Tachycardia Syndrome
Interventions
Behavioral: Hybrid Exercise Training
First Posted Date
2020-10-26
Last Posted Date
2022-03-15
Lead Sponsor
Mayo Clinic
Target Recruit Count
60
Registration Number
NCT04603157
Locations
🇺🇸

Mayo Clinic in Arizona, Scottsdale, Arizona, United States

Deep Venous Thrombus Characteristics and Venous Dynamics With Subsequent Thrombus Resolution and Post-thrombotic Syndrome

Completed
Conditions
Deep Vein Thrombosis
First Posted Date
2020-10-22
Last Posted Date
2024-01-31
Lead Sponsor
Mayo Clinic
Target Recruit Count
35
Registration Number
NCT04597138
Locations
🇺🇸

Mayo Clinic, Rochester, Minnesota, United States

A Study to Evaluate Indocyanine Green Lymphangiography to Improve Lymphadenectomy in Gastric Cancer Patients

Phase 4
Withdrawn
Conditions
Gastric Cancer
Interventions
First Posted Date
2020-10-19
Last Posted Date
2023-07-19
Lead Sponsor
Mayo Clinic
Registration Number
NCT04591028
Locations
🇺🇸

Mayo Clinic in Florida, Jacksonville, Florida, United States

Radiation Therapy, Plasma Exchange, and Immunotherapy (Pembrolizumab or Nivolumab) for the Treatment of Melanoma

Early Phase 1
Active, not recruiting
Conditions
Melanoma
Interventions
Biological: Nivolumab
Biological: Pembrolizumab
Radiation: Radiation Therapy
Biological: Therapeutic Exchange Plasma
Procedure: Biospecimen Collection
Procedure: Computed Tomography
Procedure: Positron Emission Tomography
Procedure: Magnetic Resonance Imaging
First Posted Date
2020-10-09
Last Posted Date
2024-04-29
Lead Sponsor
Mayo Clinic
Target Recruit Count
18
Registration Number
NCT04581382
Locations
🇺🇸

Mayo Clinic in Rochester, Rochester, Minnesota, United States

Lung Ultrasound Artefact Analysis for Exclusion of Acute Rejection in Lung Transplant Recipients

Not Applicable
Recruiting
Conditions
Post-Lung Transplantation Bronchiectasis
Interventions
Diagnostic Test: Lung ultrasound
First Posted Date
2020-10-09
Last Posted Date
2024-04-19
Lead Sponsor
Mayo Clinic
Target Recruit Count
90
Registration Number
NCT04582279
Locations
🇺🇸

Mayo Clinic in Florida, Jacksonville, Florida, United States

Oral Glucose Tolerance Testing Using Candy for Cystic Fibrosis

Not Applicable
Completed
Conditions
Cystic Fibrosis
Interventions
Diagnostic Test: Candy Glucose Tolerance Test
First Posted Date
2020-10-08
Last Posted Date
2022-01-20
Lead Sponsor
Mayo Clinic
Target Recruit Count
10
Registration Number
NCT04579939
Locations
🇺🇸

Mayo Clinic in Rochester, Rochester, Minnesota, United States

Letrozole in Patients With Hepatopulmonary Syndrome

Phase 2
Terminated
Conditions
Hepatopulmonary Syndrome
Interventions
Drug: Placebo
Drug: Letrozole
First Posted Date
2020-10-06
Last Posted Date
2024-05-14
Lead Sponsor
Mayo Clinic
Target Recruit Count
1
Registration Number
NCT04577001
Locations
🇺🇸

Mayo Clinic, Rochester, Minnesota, United States

© Copyright 2025. All Rights Reserved by MedPath